Venus Plastic Surgery: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Venus Plastic Surgery
Largest movements
- Cash +€48,300
up €48,300 (+4,556%), from €1,060 to €49,360
mainly Net result for the year (+€38,195) and Other debts (+€13,313)
- Tangible fixed assets +€2,183
new in 2025: €2,183
- Receivables within one year +€2,115
up €2,115 (+581%), from €364 to €2,479
of which Trade receivables: +€2,178
- Deferred charges and accrued income +€1,555
new in 2025: €1,555
- Profit (loss) carried forward +€38,195
up €38,195, from -€6,035 to €32,160
- Other debts +€13,313
up €13,313 (+1,331%), from €1,000 to €14,313
- Tax, wage and social debts +€3,880
new in 2025: €3,880
- Accrued charges and deferred income -€1,000
no longer reported in 2025 (was €1,000)
- Gross operating margin +€56,805
up €56,805, from -€6,035 to €50,770
- Taxes +€9,699
new in 2025: €9,699
- Other operating charges +€1,222
new in 2025: €1,222
- Financial charges +€971
new in 2025: €971
- Depreciation +€721
new in 2025: €721
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,424 | €55,576 | +€54,152 | +3,803% |
| Fixed assets | 21/28 | - | €2,183 | +€2,183 | |
| Tangible fixed assets | 22/27 | - | €2,183 | +€2,183 | |
| Plant, machinery and equipment | 23 | - | €2,183 | +€2,183 | |
| Current assets | 29/58 | €1,424 | €53,394 | +€51,970 | +3,650% |
| Amounts receivable within one year | 40/41 | €364 | €2,479 | +€2,115 | +581% |
| Trade receivables | 40 | - | €2,178 | +€2,178 | |
| Other amounts receivable | 41 | €364 | €301 | -€63 | -17.4% |
| Cash at bank and in hand | 54/58 | €1,060 | €49,360 | +€48,300 | +4,556% |
| Deferred charges and accrued income | 490/1 | - | €1,555 | +€1,555 | |
| Total equity and liabilities | 10/49 | €1,424 | €55,576 | +€54,152 | +3,803% |
| Equity | 10/15 | -€5,935 | €32,260 | +€38,195 | |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€6,035 | €32,160 | +€38,195 | |
| Amounts payable | 17/49 | €7,359 | €23,316 | +€15,958 | +217% |
| Amounts payable within one year | 42/48 | €6,359 | €23,316 | +€16,958 | +267% |
| Trade debts | 44 | €5,359 | €5,123 | -€235 | -4.4% |
| Suppliers | 440/4 | €5,359 | €3,323 | -€2,035 | -38.0% |
| Bills of exchange payable | 441 | - | €1,800 | +€1,800 | |
| Taxes, remuneration and social security | 45 | - | €3,880 | +€3,880 | |
| Taxes | 450/3 | - | €3,880 | +€3,880 | |
| Other amounts payable | 47/48 | €1,000 | €14,313 | +€13,313 | +1,331% |
| Accrued charges and deferred income | 492/3 | €1,000 | - | -€1,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €721 | +€721 | |
| Other operating charges | 640/8 | - | €1,222 | +€1,222 | |
| Gross operating margin | 9900 | -€6,035 | €50,770 | +€56,805 | |
| Operating profit (loss) | 9901 | -€6,035 | €48,827 | +€54,862 | |
| Financial income | 75/76B | - | €38 | +€38 | |
| Recurring financial income | 75 | - | €38 | +€38 | |
| Financial charges | 65/66B | - | €971 | +€971 | |
| Recurring financial charges | 65 | - | €971 | +€971 | |
| Profit (loss) for the period before taxes | 9903 | -€6,035 | €47,894 | +€53,929 | |
| Income taxes | 67/77 | - | €9,699 | +€9,699 | |
| Profit (loss) for the period | 9904 | -€6,035 | €38,195 | +€44,229 | |
| Profit (loss) for the period to be appropriated | 9905 | -€6,035 | €38,195 | +€44,229 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.